Nanjing Well Pharmaceutical Group Co.,Ltd.
SSE:603351.SS
29.09 (CNY) • At close June 10, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 1,296.753 | 1,155.84 | 1,111.011 | 1,042.306 | 736.064 | 880.756 | 801.451 | 694.111 | 558.444 | 498.691 | 527.598 |
| Kosten van de omzet
| 929.479 | 842.971 | 807.962 | 747.92 | 484.234 | 577.53 | 552.142 | 451.619 | 333.814 | 338.674 | 392.708 |
| Brutowinst
| 367.274 | 312.869 | 303.048 | 294.386 | 251.83 | 303.226 | 249.309 | 242.491 | 224.63 | 160.017 | 134.89 |
| Brutowinstmarge
| 0.283 | 0.271 | 0.273 | 0.282 | 0.342 | 0.344 | 0.311 | 0.349 | 0.402 | 0.321 | 0.256 |
| Onderzoek- en ontwikkelingskosten
| 71.561 | 55.645 | 53.867 | 41.459 | 36.587 | 32.913 | 24.698 | 23.277 | 17.565 | 15.173 | 15.734 |
| Algemene en administratieve kosten
| 38.976 | 46.203 | 53.698 | 35.764 | 15.543 | 15.154 | 13.481 | 18.491 | 41.83 | 13.518 | 52.131 |
| Verkoop- en marketingkosten
| 5.62 | 6.2 | 12.185 | 14.134 | 10.466 | 39.988 | 31.563 | 28.305 | 20.612 | 19.346 | 19.467 |
| Verkoop-, algemene en administratieve kosten
| 44.596 | 121.79 | 65.883 | 49.898 | 26.01 | 55.142 | 45.044 | 46.797 | 62.442 | 32.864 | 71.598 |
| Overige kosten
| 78.767 | 13.658 | 62.272 | 74.111 | 74.807 | 58.133 | 3.409 | -0.222 | -7.836 | 0.485 | 0.4 |
| Bedrijfskosten
| 194.924 | 191.093 | 182.022 | 165.468 | 137.403 | 146.188 | 115.399 | 111.385 | 121.748 | 78.798 | 73.721 |
| Bedrijfsresultaat
| 172.35 | 121.777 | 113.23 | 119.757 | 118.913 | 157.162 | 127.641 | 125.901 | 98.352 | 71.608 | 52.547 |
| Bedrijfsresultaat ratio
| 0.133 | 0.105 | 0.102 | 0.115 | 0.162 | 0.178 | 0.159 | 0.181 | 0.176 | 0.144 | 0.1 |
| Totaal overige inkomsten en kosten netto
| -0.219 | -0.335 | -0.379 | -1.021 | -0.631 | -3.043 | 3.409 | -0.222 | -19.194 | 0.485 | 0.034 |
| Inkomen voor belasting
| 172.131 | 121.441 | 112.851 | 118.735 | 118.282 | 154.119 | 131.05 | 125.678 | 90.516 | 72.092 | 52.581 |
| Inkomen voor belasting ratio
| 0.133 | 0.105 | 0.102 | 0.114 | 0.161 | 0.175 | 0.164 | 0.181 | 0.162 | 0.145 | 0.1 |
| Belastingkosten
| 26.925 | 12.327 | 18.419 | 18.586 | 17.835 | 26.011 | 19.235 | 18.243 | 16.806 | 11.364 | 7.712 |
| Nettowinst
| 146.422 | 112.199 | 95.029 | 101.37 | 100.447 | 128.108 | 111.814 | 107.432 | 73.674 | 60.671 | 44.828 |
| Nettowinstmarge
| 0.113 | 0.097 | 0.086 | 0.097 | 0.136 | 0.145 | 0.14 | 0.155 | 0.132 | 0.122 | 0.085 |
| WPA (Winst Per Aandeel)
| 1.08 | 0.83 | 0.72 | 0.78 | 0.77 | 0.98 | 1.14 | 1.1 | 0.75 | 1.07 | 0.79 |
| Verwaterde WPA
| 1.08 | 0.83 | 0.72 | 0.78 | 0.77 | 0.98 | 1.14 | 1.1 | 0.75 | 1.07 | 0.79 |
| EBITDA
| 302.579 | 209.724 | 198.286 | 168.584 | 158.697 | 194.142 | 165.047 | 155.573 | 117.431 | 98.35 | 61.169 |
| EBITDA ratio
| 0.233 | 0.181 | 0.178 | 0.162 | 0.216 | 0.22 | 0.206 | 0.224 | 0.21 | 0.197 | 0.116 |